|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-05
|
$303,240
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-03
|
$626,868
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
WDR5 as a Critical Co-Factor for MYC
|
5F31CA210429-03
|
$29,196
|
|
FOSHAGE, AUDRA
|
VANDERBILT UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Variant identification for cancer genomics
|
1R15CA220059-01A1
|
$447,460
|
|
GRIGORIEV, ANDREY
|
RUTGERS THE STATE UNIV OF NJ CAMDEN
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-03
|
$39,076
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of a Room-Temperature Storage Technique for Plasma/Serum Biospecimens
|
5R33CA204510-03
|
$338,767
|
|
AKSAN, ALPTEKIN
|
UNIVERSITY OF MINNESOTA
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-04
|
$394,823
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
5R01CA183962-04
|
$603,232
|
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
Utility of RAS mimetics to block oncogenic signaling in colorectal cancer
|
1R21CA227963-01
|
$221,198
|
|
REDDY, E
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
USP22 Function in Advanced Prostate Cancer
|
5R01CA182569-04
|
$493,498
|
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-03
|
$954,328
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
5K07CA211971-02
|
$170,636
|
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Unmet needs for specific subsets of EGFR mutated lung cancer
|
1R37CA218707-01A1
|
$409,171
|
|
COSTA, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
University of Michigan Surgical Oncology Research Training Program
|
5T32CA009672-28
|
$192,856
|
|
ZOU, WEIPING
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Iowa Surgical Oncology Training Grant
|
5T32CA148062-08
|
$420,203
|
|
WEIGEL, RONALD
|
UNIVERSITY OF IOWA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
5P30CA023074-38
|
$3,533,423
|
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Understanding the role of IDH in malignant gliomas
|
2R01CA154843-06A1
|
$384,750
|
|
MAHER, ELIZABETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Understanding the niche of minimal residual disease leukemia cells
|
2R01CA172896-06
|
$402,563
|
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Understanding the Mechanism of a Gut Microbial Genotoxin Involved in Colorectal Carcinogenesis
|
5R01CA208834-03
|
$383,091
|
|
BALSKUS, EMILY
|
HARVARD UNIVERSITY
|
|
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
|
5R01CA198089-04
|
$663,135
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Underlying Mechanisms in Angiosarcoma
|
5R01CA197943-04
|
$352,275
|
|
IRUELA-ARISPE, M
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UNC Oncology Clinical/Translational Research Training Program (OCT-RTP)
|
2K12CA120780-11
|
$547,714
|
|
KIM, WILLIAM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UM Calabresi Clinical Oncology Research Career Development Award
|
1K12CA226330-01
|
$54,000
|
|
SLINGERLAND, JOYCE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Ultrabright Theranostic SERRS Nanoparticles for Gastrointestinal Endoscopy
|
1R01CA222836-01A1
|
$716,909
|
|
KIRCHER, MORITZ
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UCSD Cancer Center Training Program in Drug Development
|
5T32CA121938-13
|
$569,911
|
|
BOUVET, MICHAEL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
|
1R01CA217333-01A1
|
$593,022
|
|
NIJHAWAN, DEEPAK
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Tumor subtypes and therapy response in pancreatic cancer
|
5R01CA199064-03
|
$591,406
|
|
YEH, JEN JEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
|
5R01CA196831-04
|
$363,713
|
|
JELINEK, DIANE
|
MAYO CLINIC ROCHESTER
|
|
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma
|
1R01CA214912-01A1
|
$629,914
|
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
Trinity: Transcriptome assembly for genetic and functional analysis of cancer
|
2U24CA180922-06
|
$821,203
|
|
REGEV, AVIV
|
BROAD INSTITUTE, INC.
|
|
Treatment of Castration-resistant Prostate Cancer (CRPC)
|
5R01CA196835-03
|
$354,563
|
|
LIU, XIAOQI
|
PURDUE UNIVERSITY
|
|
Treatment decision making in low-risk thyroid cancer
|
5R01CA201198-03
|
$518,509
|
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transporters and hematopoietic toxicity
|
5R01CA194206-03
|
$484,566
|
|
SCHUETZ, JOHN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Translational Pediatric Cancer Epidemiology Research Training Grant
|
5T32CA099936-14
|
$258,342
|
|
SPECTOR, LOGAN
|
UNIVERSITY OF MINNESOTA
|
|
Translational development studies of a novel combination therapy for castration-resistant prostate cancer
|
1R21CA218774-01A1
|
$214,380
|
|
LU, JUNXUAN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Translational Approaches to Melanoma Prevention in Children at High Genetic Risk
|
5K07CA196985-04
|
$136,555
|
|
WU, YELENA
|
UNIVERSITY OF UTAH
|
|
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
|
1R01CA218004-01A1
|
$597,598
|
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Transforming family dogs into a powerful and accessible model for human cancer
|
1R37CA218570-01A1
|
$687,174
|
|
KARLSSON, ELINOR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Transdisciplinary Research in Energetics and Cancer (TREC) Training Grant
|
5R25CA203650-03
|
$252,567
|
|
IRWIN, MELINDA
|
YALE UNIVERSITY
|
|
Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer
|
5F30CA203095-03
|
$49,524
|
|
PRIEDIGKEIT, NOLAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Transcriptional Regulation of Lung Cancer Identity
|
5R01CA212415-02
|
$336,379
|
|
SNYDER, ERIC
|
UNIVERSITY OF UTAH
|
|
Transcriptional Mechanisms of Tumor Suppression
|
5R01CA190558-04
|
$354,563
|
|
VERZI, MICHAEL
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Transcriptional Mechanisms Governing Telomerase Activity
|
5F30CA221285-02
|
$49,524
|
|
PENEV, ALEX
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
Total relevant funding to Nursing Oncology for this search: $17,541,549
|